1 |
卫飞燕, 张缭云. 慢性乙型肝炎治疗难点及热点研究进展 [J]. 中华临床感染病杂志, 2019, 12(3): 236-240.
|
2 |
Razavi-Shearer D, Gamkrelidze I, Nguyen MH, et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study [J]. Lancet Gastroenterol Hepatol, 2018, 3(6): 383-403.
|
3 |
Marlone CS, Marinho FRT, Oliveira PF, et al. Retrospective analysis of hepatitis B virus chronic infection in 247 patients: clinical stages, response to treatment and poor prognostic factors [J]. Braz J Infect Dis, 2017, 21(4): 441-447.
|
4 |
吴青青, 尹乔乔, 郑伟, 等. 慢性乙型肝炎相关肝硬化患者治疗后肝脏纤维化程度改变研究进展 [J]. 国际流行病学传染病学杂志, 2019, 46(3): 251-253.
|
5 |
Berg T, Zoulim F, Moeller B, et al. Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients [J]. J Hepatol, 2014, 60(4): 715-722.
|
6 |
Li ZQ, Hu CL, Yu P, et al. The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: incidence, long-term outcomes and predictive factors [J]. Clin Res Hepatol Gastroenterol, 2017, 41(3): 311-318.
|
7 |
罗富秀, 李用国. 慢性乙型肝炎抗病毒治疗的现状及进展 [J]. 临床与病理杂志, 2020, 40(1): 166-171.
|
8 |
刘洪媛, 柳芳, 姜廷军, 等. 瞬时弹性扫描对慢性乙型肝炎抗病毒治疗后肝脏纤维化的评价应用研究 [J]. 中国医学装备, 2018, 15(1): 74-77.
|
9 |
Jia JD, Hou JL, Ding HG, et al. Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B [J]. J Gastroenterol Hepatol, 2015, 30(4): 756-762.
|
10 |
Dong HM, Xu CZ, Zhou WY, et al. The combination of 5 serum markers compared to FibroScan to predict significant liver fibrosis in patients with chronic hepatitis B virus [J]. Clin Chim Acta, 2018, 483: 145-150.
|
11 |
Yan LB, Zhang QB, Zhu X, et al. Serum S100 calcium binding protein A4 improves the diagnostic accuracy of transient elastography for assessing liver fibrosis in hepatitis B [J]. Clin Res Hepatol Gastroenterol, 2018, 42(1): 64-71.
|
12 |
叶丽华, 王萌之, 陈佳, 等. 慢性乙型肝炎患者长期抗病毒治疗LSM和CAP值的变化及临床意义 [J]. 肝脏, 2019, 24(12): 1412-1415.
|
13 |
刘薇, 袁海霞, 时强. 抗病毒治疗慢性乙型肝炎肝硬化后肝纤维化逆转情况观察 [J]. 肝脏, 2019, 24(9): 1055-1057.
|
14 |
中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015版) [J/CD]. 中华实验和临床感染病杂志(电子版), 2015, 9(5): 570-589.
|
15 |
申婷, 游晶, 范晶华, 等. 慢性乙型肝炎抗病毒治疗研究进展 [J]. 实用医学杂志, 2014, 30(3): 339-341.
|
16 |
邓淑娟. 瞬时弹性成像技术诊断慢性乙型肝炎肝纤维化的价值分析 [J]. 中国医学工程, 2018, 26(2): 68-70.
|
17 |
袁利超, 邵金华, 郝美娜, 等. 肝脏硬度测定仪FibroTouch与FibroScan和肝脏病理分期的相关性 [J]. 中华肝脏病杂志, 2014, 22(6): 425-429.
|
18 |
张倩华, 曾梅玲, 罗宏宇, 等. 294例慢性乙型肝炎患者抗病毒治疗2年Fibroscan值的动态变化 [J]. 安徽医药, 2015, 19(9): 1799-1801.
|
19 |
Zeng XH, Cheng X, He DM, et al. Influence of hepatic inflammation on FibroScan findings in diagnosing fibrosis in patients with chronic hepatitis B [J]. Ultrasound Med Bio, 2015, 41(6): 1538-1544.
|
20 |
方正亚, 张国顺, 刘斌, 等. 肝脏硬度指标对ALT正常慢性乙型肝炎患者肝纤维化的诊断价值 [J]. 山东医药, 2017, 57(21): 61-63.
|
21 |
胡晓云, 刘智泓, 孙剑. 《2015年世界卫生组织慢性乙型肝炎病毒感染预防、关怀和治疗指南》解读:无创肝纤维化评估、抗病毒治疗策略和国家防治计划实施 [J]. 临床肝胆病杂志, 2015, 31(6): 829-832.
|
22 |
翟哲, 张超学. 实时与瞬时弹性成像在肝纤维化评价中的应用 [J]. 安徽医科大学学报, 2019, 54(5): 817-820.
|
23 |
曹发明, 张照如, 王翔. Fibroscan测定慢性乙型肝炎患者肝硬度值与肝组织活检病理学分期的相关性研究 [J]. 河北医学, 2018, 24(7): 1223-1226.
|
24 |
杨美荣, 孟冬梅, 张国顺. Fibroscan在慢性乙型肝炎合并酒精性肝病肝纤维化诊断中的价值 [J]. 山东医药, 2018, 58(9): 47-49.
|